Changes in Beneficial Ownership · 4
Bicara Therapeutics Inc.
BCAXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1785356312.xml
Filing details
- Report period
- 2026-07-28
- Issuer
- Bicara Therapeutics Inc.
- Issuer CIK
- 0002023658
- Trading symbol
- BCAX
Reporting owner 1
- Name
- Bender Jeremy
- Reporting owner CIK
- 0001863107
- Relationship
- Director
- Address
- BICARA THERAPEUTICS INC., 116 HUNTINGTON AVENUE, SUITE 703, BOSTON, MA, 02116
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 26.88 | 2026-07-28 | A · Form 4 | 38,950 | A | 0 | [F1] | 2036-07-28 | Common Stock | 38,950 | 38,950 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- One-third of the shares underlying this option shall vest and become exercisable on July 28, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.↩ 1
Signature 1
- Signed
- /s/ Ryan Cohlhepp, Attorney-in-Fact
- Date
- 2026-07-29
Recent company filings
- SCHEDULE 13G/A - filed by T. Rowe Price Investment Management, Inc. regarding Bicara Therapeutics Inc.Oct 7, 2026
- Entry into a Material Definitive AgreementAug 25, 2026
- 4 filingAug 14, 2026
- SCHEDULE 13G/A - filed by Janus Henderson Group Ltd. regarding Bicara Therapeutics Inc.Aug 13, 2026
- S-8 filingAug 11, 2026